stella
beta
Preliminary Safety and Tolerability of CD19x22 CAR T Cells in Adolescent and Adult R/R B-NHL Patients — Stella
Recruiting
Back to Non-Hodgkin Lymphoma trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
United States
University of Colorado Hospital, Aurora, Colorado
View full record on ClinicalTrials.gov